ATR Inhibition Potentiates PARP Inhibitor Cytotoxicity in High Risk Neuroblastoma Cell Lines by Multiple Mechanisms.

Southgate, Harriet E D; Chen, Lindi; Tweddle, Deborah A; Curtin, Nicola J

Southgate, Harriet E D; Chen, Lindi; Tweddle, Deborah A; Curtin, Nicola J.

Afiliação

Southgate HED; Wolfson Childhood Cancer Research Centre, Newcastle Centre for Cancer, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne NE1 7RU, UK.
Chen L; Wolfson Childhood Cancer Research Centre, Newcastle Centre for Cancer, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne NE1 7RU, UK.
Tweddle DA; Wolfson Childhood Cancer Research Centre, Newcastle Centre for Cancer, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne NE1 7RU, UK.
Curtin NJ; Newcastle Centre for Cancer, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne NE2 4HH, UK.

Cancers (Basel) ; 12(5)2020 Apr 28.

Article em En | MEDLINE | ID: mdl-32354033

Palavras-chave

ataxia telangiectasia and Rad3 related inhibitors (ATRi); cell cycle checkpoints; poly (ADP-ribose) polymerase inhibitors (PARPi); replication stress

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google